Published in J Orthop Res on July 01, 2009
In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev (2010) 1.23
Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther (2013) 1.16
Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med (2011) 1.09
Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. Biomed Res Int (2014) 0.95
Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis. Stem Cells (2013) 0.93
Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater (2011) 0.93
Concise review: cell-based strategies in bone tissue engineering and regenerative medicine. Stem Cells Transl Med (2013) 0.92
Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology? Transfus Med Hemother (2010) 0.91
In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J Tissue Eng Regen Med (2011) 0.89
A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice. Stem Cell Res Ther (2013) 0.79
Osteoblast-released Matrix Vesicles, Regulation of Activity and Composition by Sulfated and Non-sulfated Glycosaminoglycans. Mol Cell Proteomics (2015) 0.78
Simple evaluation method for osteoinductive capacity of cells or scaffolds using ceramic cubes. Tissue Cell (2014) 0.78
Cell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem Cells. Biomacromolecules (2015) 0.78
Calcium sensing receptor expression in ovine amniotic fluid mesenchymal stem cells and the potential role of R-568 during osteogenic differentiation. PLoS One (2013) 0.78
Mesenchymal stem cell expression of SDF-1β synergizes with BMP-2 to augment cell-mediated healing of critical-sized mouse calvarial defects. J Tissue Eng Regen Med (2015) 0.78
Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone. Mediators Inflamm (2013) 0.77
The role of gap junctions and mechanical loading on mineral formation in a collagen-I scaffold seeded with osteoprogenitor cells. Tissue Eng Part A (2015) 0.75
Osteogenic Differentiation of Mesenchymal Stem Cells by Mimicking the Cellular Niche of the Endochondral Template. Tissue Eng Part A (2016) 0.75
Application of Green Tea Catechin for Inducing the Osteogenic Differentiation of Human Dedifferentiated Fat Cells in Vitro. Int J Mol Sci (2015) 0.75
The effect of deproteinized bovine bone mineral on saos-2 cell proliferation. Iran Endod J (2013) 0.75
Directing the osteoblastic and chondrocytic differentiations of mesenchymal stem cells: matrix vs. induction media. Regen Biomater (2017) 0.75
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
In search of the in vivo identity of mesenchymal stem cells. Stem Cells (2008) 4.17
Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev (2009) 3.73
Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 3.65
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med (2013) 2.60
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med (2009) 2.31
The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs (2002) 1.95
Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. Nat Neurosci (2012) 1.86
Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues Organs (2006) 1.82
Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials (2007) 1.78
Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A (2008) 1.70
Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol (2006) 1.60
Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem (2002) 1.56
Adult stem cell driven genesis of human-shaped articular condyle. Ann Biomed Eng (2004) 1.56
Fibroblast heterogeneity: more than skin deep. J Cell Sci (2004) 1.55
Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol (2010) 1.46
Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol (2009) 1.46
Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A (2010) 1.45
Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A (2010) 1.38
Mesenchymal stem cells in tissue repair. Front Immunol (2013) 1.35
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Isolation of rat marrow-derived mesenchymal stem cells. Exp Hematol (2006) 1.29
Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther (2010) 1.28
Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther (2010) 1.28
Fibroblasts-a diverse population at the center of it all. Int Rev Cell Mol Biol (2009) 1.27
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A (2009) 1.22
MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A (2009) 1.21
Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng (2002) 1.20
Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng (2007) 1.19
Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A (2009) 1.18
Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules (2009) 1.18
Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J (2002) 1.15
Targeted delivery of progenitor cells for cartilage repair. J Orthop Res (2004) 1.15
One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One (2012) 1.12
Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage (2005) 1.11
Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng (2002) 1.09
Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54. J Cell Physiol (2006) 1.09
Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. Methods Mol Med (2004) 1.07
Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials (2009) 1.06
Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond) (2010) 1.06
Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue Eng Part A (2010) 1.04
A rapid seeding technique for the assembly of large cell/scaffold composite constructs. Tissue Eng (2006) 1.03
In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(epsilon-caprolactone) scaffolds. Biomaterials (2010) 1.02
Efficient osteoclast differentiation requires local complement activation. Blood (2010) 1.02
The potential of mesenchymal stem cells for neural repair. Discov Med (2010) 1.01
Hyaluronan-based scaffolds to tissue-engineer cartilage implants for laryngotracheal reconstruction. Laryngoscope (2007) 1.01
Tissue engineering of autologous cartilage grafts in three-dimensional in vitro macroaggregate culture system. Tissue Eng (2005) 1.00
Fabrication of a neotrachea using engineered cartilage. Laryngoscope (2008) 0.98
Scaling-up of dental pulp stem cells isolated from multiple niches. PLoS One (2012) 0.98
The effects of crosslinking of scaffolds engineered from cartilage ECM on the chondrogenic differentiation of MSCs. Biomaterials (2013) 0.98
Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem (2003) 0.98
A self-assembled fibroblast-endothelial cell co-culture system that supports in vitro vasculogenesis by both human umbilical vein endothelial cells and human dermal microvascular endothelial cells. Cells Tissues Organs (2007) 0.96
Age-related differences in human skin proteoglycans. Glycobiology (2010) 0.96
Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med (2010) 0.96
Methods for producing scaffold-free engineered cartilage sheets from auricular and articular chondrocyte cell sources and attachment to porous tantalum. Biores Open Access (2012) 0.96
Nondestructive evaluation of hydrogel mechanical properties using ultrasound. Ann Biomed Eng (2011) 0.96
Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev (2014) 0.96
Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev (2011) 0.95
A simple method for stem cell labeling with fluorine 18. Nucl Med Biol (2005) 0.94
Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clin Orthop Relat Res (2006) 0.93
Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging. Physiol Genomics (2008) 0.93
Dexamethasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells. J Orthop Res (2009) 0.93
The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds. Biomaterials (2012) 0.92
Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions. Wound Repair Regen (2008) 0.91
Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A (2013) 0.89
Scaffold-free tissue-engineered cartilage implants for laryngotracheal reconstruction. Laryngoscope (2010) 0.89
Growth, differentiation capacity, and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp Cell Res (2013) 0.88
Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction. PLoS One (2011) 0.88
Effect of transforming growth factor beta 2 on marrow-infused foam poly(propylene fumarate) tissue-engineered constructs for the repair of critical-size cranial defects in rabbits. Tissue Eng (2005) 0.88
Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target (2011) 0.87
Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers. J Control Release (2004) 0.87
Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition. Biochem J (2012) 0.87
Imaging stem cell implant for cellular-based therapies. Exp Biol Med (Maywood) (2008) 0.87
Clonal characterization of fibroblasts in the superficial layer of the adult human dermis. Cell Tissue Res (2006) 0.87
Validating continuous digital light processing (cDLP) additive manufacturing accuracy and tissue engineering utility of a dye-initiator package. Biofabrication (2014) 0.86
Osteochondral defect repair by demineralized cortical bone matrix. Clin Orthop Relat Res (2004) 0.86
Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities. Stem Cells Transl Med (2012) 0.85
Cellular interactions and bone healing responses to a novel porous tricalcium phosphate bone graft material. Orthopedics (2004) 0.84
A comparison of five treatment protocols for contaminated bone grafts in reference to sterility and cell viability. J Bone Joint Surg Am (2011) 0.84
Low oxygen tension during incubation periods of chondrocyte expansion is sufficient to enhance postexpansion chondrogenesis. Tissue Eng Part A (2010) 0.84
Tissue-engineered trachea for airway reconstruction. Laryngoscope (2009) 0.82
The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells. Stem Cells Transl Med (2012) 0.81
Production of a monoclonal antibody, DF-5, that identifies cells at the epithelial-mesenchymal interface in normal human skin. APN/CD13 is an epithelial-mesenchymal marker in skin. Exp Dermatol (2003) 0.81